News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,417 Results
Type
Article (57779)
Company Profile (304)
Press Release (639315)
Multimedia
Podcasts (178)
Webinars (32)
Section
Business (180894)
Career Advice (2619)
Deals (33273)
Drug Delivery (166)
Drug Development (86031)
Employer Resources (178)
FDA (17269)
Job Trends (14308)
News (325825)
Policy (33851)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2806)
Academic (1)
Accelerated approval (48)
Adcomms (37)
Allergies (176)
Alliances (47633)
ALS (213)
Alzheimer's disease (1907)
Antibody-drug conjugate (ADC) (463)
Approvals (17534)
Artificial intelligence (711)
Autoimmune disease (280)
Automation (53)
Bankruptcy (342)
Best Places to Work (11120)
BIOSECURE Act (23)
Biosimilars (229)
Biotechnology (202)
Bladder cancer (191)
Brain cancer (75)
Breast cancer (736)
Cancer (5885)
Cardiovascular disease (512)
Career advice (2222)
Career pathing (48)
CAR-T (339)
CDC (73)
Celiac Disease (2)
Cell therapy (920)
Cervical cancer (47)
Clinical research (73957)
Collaboration (2139)
Company closure (6)
Compensation (1345)
Complete response letters (100)
COVID-19 (2977)
CRISPR (110)
C-suite (1091)
Cystic fibrosis (161)
Data (7674)
Decentralized trials (3)
Denatured (52)
Depression (179)
Dermatology (73)
Diabetes (596)
Diagnostics (7025)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (341)
Drug pricing (237)
Drug shortages (37)
Duchenne muscular dystrophy (293)
Earnings (74679)
Editorial (75)
Employer branding (20)
Employer resources (155)
Events (107549)
Executive appointments (1083)
FDA (20964)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1744)
Gene editing (244)
Generative AI (65)
Gene therapy (766)
GLP-1 (1212)
Government (4998)
Grass and pollen (8)
Guidances (403)
Healthcare (18454)
HIV (84)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (336)
Immuno-oncology (97)
Indications (173)
Infectious disease (3341)
Inflammatory bowel disease (227)
Inflation Reduction Act (15)
Influenza (143)
Intellectual property (287)
Interviews (488)
IPO (16563)
IRA (58)
Job creations (3536)
Job search strategy (1815)
JPM (70)
Kidney cancer (20)
Labor market (100)
Layoffs (654)
Leadership (48)
Legal (7709)
Liver cancer (106)
Longevity (30)
Lung cancer (790)
Lymphoma (430)
Machine learning (61)
Management (58)
Manufacturing (1017)
MASH (196)
Medical device (13470)
Medtech (13554)
Mergers & acquisitions (17919)
Metabolic disorders (1614)
mRNA (229)
Multiple sclerosis (191)
NASH (24)
Neurodegenerative disease (446)
Neuropsychiatric disorders (118)
Neuroscience (3490)
Neurotech (2)
NextGen: Class of 2026 (6311)
Non-profit (4568)
Now hiring (61)
Obesity (793)
Opinion (336)
Ovarian cancer (211)
Pain (256)
Pancreatic cancer (296)
Parkinson's disease (380)
Partnered (32)
Patents (587)
Patient recruitment (654)
Peanut (65)
People (54971)
Pharmaceutical (69)
Pharmacy benefit managers (36)
Phase 1 (22918)
Phase 2 (32307)
Phase 3 (24455)
Pipeline (7911)
Policy (372)
Postmarket research (2899)
Preclinical (9866)
Press Release (50)
Prostate cancer (301)
Psychedelics (65)
Radiopharmaceuticals (322)
Rare diseases (1152)
Real estate (5284)
Recruiting (70)
Regulatory (26659)
Reports (59)
Research institute (2623)
Resumes & cover letters (430)
Rett syndrome (37)
RNA editing (25)
RSV (97)
Schizophrenia (185)
Series A (300)
Series B (218)
Service/supplier (11)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (183)
Sponsored (52)
Startups (3532)
State (1)
Stomach cancer (21)
Supply chain (132)
Tariffs (104)
The Weekly (124)
Vaccines (1239)
Venture capital (116)
Weight loss (547)
Women's health (122)
Worklife (24)
Date
Today (188)
Last 7 days (739)
Last 30 days (2877)
Last 365 days (31434)
2026 (10487)
2025 (31407)
2024 (35778)
2023 (40257)
2022 (51466)
2021 (55607)
2020 (53580)
2019 (44923)
2018 (33942)
2017 (33081)
2016 (32247)
2015 (36562)
2014 (29471)
2013 (24446)
2012 (25772)
2011 (26247)
2010 (24458)
Location
Africa (888)
Alabama (89)
Alaska (6)
Arizona (304)
Arkansas (16)
Asia (41578)
Australia (7202)
California (12822)
Canada (3473)
China (1354)
Colorado (535)
Connecticut (572)
Delaware (395)
Europe (97947)
Florida (1919)
Georgia (395)
Hawaii (4)
Idaho (63)
Illinois (1003)
India (83)
Indiana (586)
Iowa (24)
Japan (523)
Kansas (126)
Kentucky (50)
Louisiana (42)
Maine (82)
Maryland (1563)
Massachusetts (9281)
Michigan (334)
Minnesota (700)
Mississippi (7)
Missouri (143)
Montana (32)
Nebraska (28)
Nevada (133)
New Hampshire (80)
New Jersey (3445)
New Mexico (29)
New York (3379)
North Carolina (1667)
North Dakota (10)
Northern California (6396)
Ohio (387)
Oklahoma (21)
Oregon (47)
Pennsylvania (2507)
Puerto Rico (27)
Rhode Island (45)
South America (1233)
South Carolina (85)
South Dakota (2)
Southern California (5023)
Tennessee (195)
Texas (2034)
United States (45412)
Utah (367)
Vermont (1)
Virginia (321)
Washington D.C. (78)
Washington State (1039)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
697,417 Results for "alzheimer s disease data initiative".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
March 18, 2026
·
8 min read
Press Releases
Cognito Therapeutics Presents New Data on Spectris™ in Alzheimer’s Disease at AD/PD™ 2026
March 17, 2026
·
3 min read
Press Releases
IGC Pharma to Showcase AI Platform with Alzheimer’s Disease Data Initiative at ADPD 2026
March 18, 2026
·
4 min read
Press Releases
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
March 23, 2026
·
7 min read
Press Releases
Priavoid to Present Initial Phase 2 Safety Data for Alzheimer‘s and Preclinical PoC for Parkinson‘s Programs at AD/PD™ 2026
March 5, 2026
·
2 min read
Press Releases
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
March 16, 2026
·
5 min read
Press Releases
Priavoid Presents Initial Phase 2 Data Suggesting Favorable Safety Profile for Alzheimer’s Candidate PRI-002 at AD/PD™ 2026
March 17, 2026
·
4 min read
Press Releases
Amlogenyx Announces Positive Preclinical Data on AM805, a Potent Amyloid-Degrading Protease for the Treatment of Alzheimer’s Disease
March 16, 2026
·
4 min read
Press Releases
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program
• Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials • Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems
March 23, 2026
·
7 min read
Press Releases
Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
March 11, 2026
·
5 min read
1 of 69,742
Next
